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Abstract. At the end of 1985 there were 5482 patients
known to the Registry who started renal replacement
therapy (RRT) between the ages of 6 months and 15 years.
Of these, approximately 25% had died, 30% were still
aged less than 15 years, and the other 45% were older. The
acceptance rate of new patients over the last 10 years has
slowly but steadily increased; six new paediatric patients
per million child population probably represents the
likely needs of the near future.
Hospital haemodialysis remained the main form of
renal replacement therapy in new patients, while 3 years
after start of RRT, transplantation became the most
frequently used replacement therapy; CAPD appeared to
be used mainly in children with a short waiting time for
transplantation.
Out of the 384 grafts reported in 1985, only 16% were
from living related donors; among 321 cadaver grafts,
24% were second and only 3% were third grafts.
Glomerulonephritis and pyelonephritis accounted for
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50% of all primary renal diseases. During the last 5 years,
the proportion with glomerulonephritis seems to have
decreased slightly. Hyperkalaemia and fluid overload
have still to be considered the main causes of death. Only
in 17% of all cases was the cause of death reported as
unknown or undetermined.
Key words: Children; Demography; Dialysis; End-stage
renal failure; Transplantation
Introduction
Since 1972, data collected by the EDTA Registry on chil-
dren treated by renal replacement therapy (RRT) have
been presented annually and published in the Proceedings
of EDTA-ERA. The data up to 31 December 1984 were
published in the journal of the Association [1].
This report is based on data provided on individual
patient questionnaires and relates to treatment up to 31
December 1985. Demographic data on patients who
commenced treatment for end-stage renal failure aged less
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than 15 years are presented. Numbers of patients alive on
different forms of therapy and numbers of new patients
accepted for treatment are given. Types of therapy used
in the treatment of children, causes of end-stage renal
failure, and causes of death in these patients are also
discussed.
Methods
The Paediatric Registry Data Base
The methods of data collection used by the EDTA
Registry have previously been described [1]. The term
'specialised paediatric centre' has been used for those
centres which defined themselves as a specialised dialysis
centre for paediatric patients in response to a question on
the centre questionnaire. Demographic data are
Table 1. Number of patients ever accepted for treatment of end-stage
renal failure aged more than 6 months and less than 15 years. The
number of these patients alive on 31 December 1985 is also given. Data
from patient questionnaire
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total
Total number
ofpaedialric
patients
registered
17
71
185
46
5
38
85
31
723
42
1050
139
66
25
2
43
115
582
4
10
8
I
224
53
124
66
519
86
95
6
47
854
120
5482
Untraced*
6
2
9
4
—
II
2
78
2
88
1
28
—
2
8
51
3
3
—
42
—
8
1
30
2
1
5
92
19
498
Alive on
31 Dec. 1985
9
48
141
10
5
17
48
18
479
29
756
79
17
16
2
32
71
396
0
2
4
1
153
45
72
52
389
64
74
4
16
548
57
3654
expressed both as absolute numbers and per million child
population (PMCP). Data on child populations were
obtained from the World Health Organisation Statistics
Annual, using the most up-to-date information available
for each country.
Results and Comments
On 31 December 1985, the Registry held records for 5482
patients who started RRT aged more than 6 months and
less than 15 years (Table 1). After excluding 498 patients
who were lost to follow-up, whose records had not been
updated, or where there was an invalid treatment code,
3654 patients were registered alive at the end of 1985 on a
known form of therapy; after excluding patients who had
recovered their renal function, 1616 were still aged less
than 15 years, and 2003 were older than 15 on that date. A
total of 1330 patients had died. For the total Registry,
Table 2. Number of new paediatric patients accepted onto renal replace-
ment therapy in 1985 shown according to age group. The Table is based
on information provided on the 1985 patient questionnaire, and shows
the total number of new patients per million child population (PMCP)
*Lost to follow-up, not updated or current method of treatment
unknown, uncertain
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total
%
Age groups
0-4
0
0
4
0
0
0
1
0
9
0
17
2
0
0
0
0
3
12
0
0
0
0
7
1
3
0
5
2
1
0
2
7
3
79
15.4
5-9
0
0
5
0
0
1
2
5
17
1
31
1
2
5
0
2
3
14
0
0
0
0
8
3
7
3
15
2
1
0
0
20
6
154
29.8
10-14
0
5
7
0
0
2
3
3
29
2
49
9
2
3
0
.2
5
31
0
0
0
0
5
1
18
10
30
3
5
0
8
46
5
283
54.8
Total
0
5
16
0
0
3
6
8
55
3
97
12
4
8
0
4
11
57
0
0
0
0
20
5
28
13
50
7
7
0
10
73
14
516
100
PMCP
2.8
7.2
0.9
5.2
0.5
4.1
2.8
7.9
3.4
1.8
3.7
4.1
9.7
4.2
5.8
5.2
3.4
5.4
5.2
4.1
5.0
0.5
5.6
2.5
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Table 3. Stock of paediatric patients alive on a known form of renal replacement therapy on 31 December 1985. The number of patients
who have recovered sufficient function of own kidneys to make dialysis unnecessary is recorded separately. The Table only includes
patients who commenced treatment under the age of 15 and who were still aged less than 15 at the end of 1985. The number of patients alive
per million child population (PMCP) is also given. Data from patient questionnaire
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Country
Algeria
Austria
Belgium
Bulgaria
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total
%
Hospital HD
7
9
22
5
3
5
6
44
2
171
31
2
8
1
I"
4
73
1
0
17
1
28
24
77
1
8
1
11
32
24
619
38
Home HD
0
0
0
0
0
0
0
3
0
6
0
0
0
0
0
0
3
I
0
0
0
0
0
1
0
0
0
0
6
0
20
1
IPD
0
0
0
0
0
I
1
6
0
4
0
0
0
0
0
0
3
0
0
0
0
0
1
2
0
0
0
0
2
0
20
1
CAPD
0
0
3
0
0
7
1
26
2
21
0
3
0
1
1
7
26
0
0
21
2
II
3
15
2
6
0
0
53
2
213
13
Graft
0
9
47
0
5
6
6
96
7
153
8
2
4
0
12
28
55
1
1
38
12
7
1
79
20
12
0
0
133
2
744
47
Total
7
18
72
5
8
19
14
175
11
355
39
7
12
2
14
39
160
3
1
76
15
46
29
174
23
26
1
11
226
. 28
1616
100
PMCP
1
12
37
2
2
19
1
18
It
30
13
3
5
33
14
28
13
50
0
25
19
5
13
18
15
24
1
1
20
5
Recovery*
0
0
0
0
0
0
1
4
0
5
3
0
0
0
0
0
3
0
0
0
1
0
2
3
0
1
0
0
2
0
25
'Recovery of function.
7-
6-
5-
PMCP
2-
1976 1977 1978 1979 1980 1981 1982 1983 1984 1985
Fig. 1. Acceptance rate of new paediatric patients on renal replacement
programmes in the five largest European countries between 1976 and
1985, expressed per million child population (PMCP). FRA, France;
UK. United Kingdom; SPA. Spain; IT A. Italy and FRG. Federal
Republic of Germany.
information was available for 89.5% of known live
paediatric patients. Of patients aged less than 15 on 31
December 1985, 94% had updated records. The number
of patients who started RRT aged less than 15 and who
were alive at the end of 1985 varied widely between
countries when expressed per million child population.
In those countries where a programme for the treatment
of children with end-stage renal failure (ESRF) began in
the early seventies, it ranged between 30 and 60 PMCP.
There were 89 (4.5%) centres defining themselves as spe-
cialised units on the centre questionnaire in 1985. It is
interesting to note that 86 (97%) returned 1985 patient
questionnaires. The proportion of all children who were
treated in these specialised units varied between countries,
but in the majority, more than 80% of patients aged less
than 15 were treated in specialised paediatric centres.
New Patients in 1985
During 1985,516 new paediatric patients were reported to
have been accepted for treatment; 15% were aged less
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Table 4. Percentage contribution of different modes of therapy to the treatment of children at specified intervals
after start of renal replacement therapy shown for selected countries. All children commencing RRT in 1981—85
are included. An asterisk (•) denotes less than 30 patients at risk. Nordic countries are Denmark, Finland,
Norway and Sweden
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France
Fed. Rep.
Germany
Italy
Nordic
countries
Spain
United
Kingdom
Hosp. HD
Home HD
CAPD
IPD
Graft
n
Hosp. HD
Home HD
CAPD
IPD
Graft
n
Hosp. HD
HomeHD
CAPD
IPD
Graft
n
Hosp. HD
Home HD
CAPD
IPD
Graft
n
Hosp. HD
HomeHD
CAPD
IPD
Graft
n
Hosp. HD
Home HD
CAPD
IPD
Graft
n
Start
RRT
76
0
15
8
1
390
75
1
15
7
4
252
74
0
19
4
3
202
37
0
29
14
20
94
65
0
12
21
3
234
45
0
30
14
11
333
6 months
79
4
12
3
2
356
64
1
17
5
12
228
68
2
21
2
7
174
25
1
31
1
41
80
66
<1
16
6
11
219
33
2
35
3
27
312
1 year
73
6
10
2
8
328
57
3
14
5
22
220
60
3
20
1
16
160
22
1
25
0
51
76
62
2
13
4
19
201
26
4
27
2
40
306
2 years
58
6
8
2
26
296
46
4
10
3
37
186
53
5
15
I
27
131
23
0
17
5
54
74
55
3
9
2
32
170
24
5
19
2
50
295
3 years
48
5
4
2
41
190
38
4
4
2
52
127
49
6
12
2
31
94
24
0
5
0
70
37
46
4
4
1
46
154
17
4
17
0
62
174
4 years
41
4
4
1
50
102
28
3
1
1
66
68
48
7
11
2
31
54
•
41
4
4
2
50
56
14
10
19
1
55
91
than 5 years, 30% were 5-9 years old, and 55% were more
than 10 but less than 15 years (Table 2). The acceptance
rate in 1985 varied widely between different European
countries, even amongst the larger countries (4.2 new
patients PMCP in Italy to 7.9 PMCP in France). Never-
theless, it is important to note that there has been a
gradual overall increase in the acceptance rates over the
past 10 years in all countries (Fig. 1). Some countries, such
as France, may have a very high acceptance rate due to
the acceptance of foreign patients. Even so, it appears
reasonable to assume that 6 new children PMCP probably
represent the likely needs for the near future; this figure is
supported by the results of the Canadian Paediatric
Registry which obtains comprehensive data on children
with end-stage renal failure in that country [2]. However,
this figure may be influenced over the next 10 years by a
decrease in the birth rate or increased quality of conserva-
tive treatment or by the likely increase in the acceptance
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Table 5. Transplant activity in 1985. based on data from patient questionnaire. The Table gives the number of grafts
performed during 1985 in children aged less than 15 at time of grafting
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Country
Austria
Belgium
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Ireland
Israel
Italy
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
United Kingdom
Yugoslavia
Total
Live donor
1st
1
3
0
0
3
4
0
3
0
1
1
5
2
7
1 •
2
3
0
9
6
0
0
5
2
58
2nd
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
2
0
0
1
0
5
Total
1
4
0
0
3
4
0
4
0
1
I
5
2
7
1
2
3
0
9
8
0
0
6
2
63
Cadaver donor
1st
4
6
2
2
0
24
2
47
7
0
0
1
8
12
14
1
5
2
45
3
3
1
45
0
234
2nd
3
1
0
1
0
12
1
11
1
0
0
2
1
4
3
2
0
0
10
0
I
0
23
0
76
3rd
I
0
0
0
0
I
0
0
0
0
0
I
0
0
0
0
0
0
1
0
0
0
6
0
10
4th
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
Total
8
7
2
3
0
37
3
58
8
0
0
4
9
16
17
3
5
2
56
3
4
1
75
0
321
All
grafts
9
11
2
3
3
41
3
62
8
1
1
9
11
23
18
5
8
2
65
11 •
4
1
81
2
384
70-j
60-
50-
Per
cent 4 0 -
30-
20-
10-
0 -
NOROIC
FRG
1 2 3
Years after 1st RFtT
Fig. 2. Proportional contribution of grafting to the treatment of children
who commenced renal replacement therapy between 1981 and 1985 at
different intervals after first treatment. Results are given for six countries
or groups of countries. NORDIC: Denmark. Finland. Norway and
Sweden: FRG. Federal Republic of Germany: UK. United Kingdom:
SPA, Spain: FRA, France; IT A, Italy.
rate of younger children and infants with end-stage renal
failure.
Mode of treatment on 31 December 1985
Table 3 shows the mode of treatment used in patients aged
under 15 on 31 December 1985, and alive on a known
form of renal therapy on that date. Almost half of these
patients were alive with a functioning graft; the majority
of the remaining patients were treated by hospital
haemodialysis, and a small proportion by CAPD; home
haemodialysis and IPD accounted for only 2% of all
renal replacement therapy in this group of patients. If
only new patients are considered, the proportional con-
tribution of CAPD becomes more important and ac-
counts, on average, for 20% of new patients [3]
although there are striking differences between countries
(Table 4).
Treatment Mode in Relation to Time on RRT
The methodology developed by Dr Neville Selwood and
previously described [4] was used to analyse the pro-
portional contribution of different modes of renal replace-
ment therapy to the treatment of children at specified
intervals after the start of RRT. In this analysis therefore
the starting point for each patient was the date of the first
treatment. All children commencing RRT in 1981 (85
aged less than 15) were included. Only 4% of children
commenced with transplantation, hospital haemodialysis
accounted for 67% of first treatment, IPD 11%, and
CAPD 17%. By 3 years the pattern was very different,
with functioning grafts now maintaining 46% of those
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Table 6. Proportional distribution of causes of end-stage renal failure in patients aged less than 15 when commencing renal
replacement therapy 1981 -85. Numbers of patients with each cause of end-stage renal failure are also shown
Causes of end-stage renal failure
Chronic renal failure, aetiology uncertain 135 5.7%
Glomerulonephritis 611 25.8%
histologically not examined 131
severe nephrotic syndrome with focal sclerosis 161
IgA ncphropathy (proven by immunofluorescence)* 11
dense-deposit disease (proven by immunofluorescence and/or electronmicroscopy)** 18
other glomerulonephritis. histologically examined 290
Pyelonephritis/interstitial nephritis 574 24.2%
cause not specified 77
associated with neurogenic bladder 31
due to congenital obstructive uropathy with or without vesicoureteric reflux 237
due to acquired obstructive uropathy 19
due to vesicoureteric reflux without obstruction 184
due to urolithiasis 12
due to other causes 14
Hereditary/familial nephropathy 370 15.6%
cystic kidney disease, type unspecified 11
polycystic kidneys, adult type (dominant) 10
polycystic kidneys, infantile (recessive) 28
medullary cystic disease, including nephronophthisis 150
other specified type of cystic kidney disease 9
hereditary/familial nephropathy. type unspecified 15
hereditary nephritis with nerve deafness (Alport's syndrome) 38
cystinosis 75
primary oxalosis 22
other hereditary nephropathy 12
Congenital hypoplasia/dysplasia 319 13.5%
congenital hypoplasia, type unspecified 137
oligomeganephronic hypoplasia 36
segmental renal hypoplasia (Ask-Upmark kidney) 8
congenital renal dyspiasia with or without urinary-tract malformation 120
syndrome of agenesis of abdominal muscles (Prune-belly syndrome) 18
Renal vascular disease 37 1.6%
type unspecified 6
due to malignant hypertension (no primary renal disease) 5
due to hypertension (no primary renal disease) 14
due to polyarteritis 4
Wegener's granulomatosis 1
other renal vascular disease, classified 7
Multisystem disease 243 10.2%
diabetes, insulin dependent (Type I) 9
diabetes, non-insulin dependent (Type II) 3
myelomatosis 1
amyloid 8
lupus erythematosus 19
Henoch-Schonlein purpura 56
Goodpasture's syndrome 2
Haemolytic-uraemic syndrome (Moschcowitz syndrome) 115
other multisystem disease 30
Miscellaneous 83 3.4%
nephropathy caused by drugs 10
cortical or tubular necrosis 19
nephrocalcinosis and hypercalcaemic nephropathy 14
kidney tumour 17
traumatic or surgical loss of kidney 6
other identified renal disorders i 7
•Introduced in 1983.
••Introduced in 1984.
alive on treatment, hospital haemodialysis 41%, home different forms of therapy at various time intervals is given
haemodialysis 3%, and CAPD approximately 8%. This for France, the Federal Republic of Germany, Italy,
distribution was very different according to country, as the Nordic countries (Denmark, Finland, Norway and
shown in Table 4, where the proportional contribution of Sweden), Spain, and the United Kingdom.
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Table 7. Proportional distribution of groups of primary renal diseases recorded as cause of end-stage
renal failure in patients aged less than IS years commencing treatment in each of the years 1981—85
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Causes of end-stage renal failure
in new patients from 1981 to 1985
Chronic renal failure, aetiology uncertain
Glomerulonephritis
Pyelonephritis/interstitial nephritis
Hereditary familial nephropathy
Congenital hypoplasia/dysplasia
Renal vascular disease
Multisystem disease
Other
1981
(%)
5.9
29.7
22.8
15.9
12.3
1.4
9.7
2.1
1982
(%)
5.3
23.8
26.1
12.3
13.7
1.8
14.4
2.3
1983
(%)
6.0
25.9
22.1
18.4
12.8
2.0
8.6
4.0
1984
(%)
4.8
26.4
27.9
12.9
12.7
1.3
11.6
2.2
1985
(%)
6.3
23.2
21.8
18.1
15.5
1.2
7.1
6.5
Transplantation activity
Transplantation activity in children during 1985 is
summarised in Table 5. This shows the graft according to
the country where the child was registered on 31
December 1985, and does not necessarily indicate where
the transplant was performed. Out of a total of 384 grafts
that were reported in 1985,16% were from a living donor.
Among cadaver grafts, 26% were regrafts (40% in the
UK) and only 10 (3%) were third grafts; only one fourth
graft was reported.
Achievement in transplantation for children was also
studied using the Selwood method. There were national
differences in the contribution of transplantation to the
treatment of children who commenced RRT during the 5
years between 1981 and 1985, as shown in Table 4 and Fig.
2. In Nordic countries, which include Denmark, Finland,
Norway and Sweden, over 50% of children had a function-
ing transplant by 1 year after start of treatment, compared
with 10%-20% in France and Italy, 20%-30% in Spain
and the Federal Republic of Germany, and over40% in the
United Kingdom. By 2 years, the 50% mark had been
passed by the United Kingdom, and by 4 years, this figure
had also been reached by the Federal Republic of
Germany, France and Spain. In interpreting these data, it
is necessary to bear in mind the number of children alive on
renal replacement therapy in each country, given in Table
1. The size of the treated paediatric population in some
countries may explain the difficulty encountered in achiev-
ing early grafting; alternatively, the observed differences
may reflect different policies.
Primary Renal Disease
The proportional distribution of causes of end-stage renal
failure (ESRF) in children who started renal replacement
therapy between 1981 and 1985, as reported to the
Registry, is shown in Table 6. Glomerulonephritis and
pyelonephritis accounted for approximately 25% each of
all primary renal diseases; hereditary and/or familial
nephropathies were responsible for 15.6% of cases of
ESRF, followed by congenital hypoplasias and dysplasias
(13.5%) and multisystem disease (10.2%). It is worth
noting that in only 5.7% of the 2372 children who started
RRT from 1981 to 1985 was the aetiology of chronic renal
failure considered uncertain; this figure was much smaller
than in adults.
When the proportional distribution of different groups
of primary renal diseases in each of the 5 years is con-
sidered, a definite trend is not seen, except perhaps for
glomerulonephritis (Table 7) which accounted for almost
30% of all primary renal diseases in 1981, but for only
23% in 1985, thus confirming the trends already described
in the preceeding years. It is not possible to say if this fact
reflects a reduction of the incidence of glomerular
diseases, a modification in the diagnostic practice, or
an increased acceptance of patients with non-glomerular
diseases.
Causes of Death
Table 8 shows the causes of death in patients who died on
RRT aged less than 15 years during the period 1981-1985.
The causes of death have been grouped under several
headings. Cause of death uncertain/not determined/
unknown, cardiac arrest, cause unknown, as well as cases
where a cause of death was not recorded, have been
grouped together; they represented a relatively small
proportion of the total.
Hyperkalaemia and fluid overload have been con-
sidered separately and accounted for half of the known
'cardiac' causes. These latter causes, unfortunately, relate
to either non-compliance or poor dialysis strategy; the
proportion was much higher than in adult patients (4.9%)
and is probably specifically related to the difficulty of
dialysis management in children. These data confirm the
previous finding that excess weight gain (weight gain
between haemodialysis treatments exceeding 8% of body
weight at least once a week) is associated with excess mor-
tality [5]. Infection also represented an important cause of
death in children on RRT.
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Table 8. Proportional distribution of causes of death in patients who died on RRT aged less than IS years during the
years 1981 85. Numbers of patients with each cause of death recorded are also shown
Cause of death on renal replacement therapy Deaths 1981-85
Cause of death not given
uncertain/not determined/unknown
cardiac arrest, cause unknown
Cardiac
Vascular
Infection
Liver disease
Gastro-intestinal
Social
Miscellaneous
Accident
Total
Myocardial ischaemia and infarction
Haemorrhagic pericarditis
Hypertensive cardiac failure
Other causes of cardiac failure
Hypokalaemia
Hyperkalaemia
Fluid overload
Pulmonary embolus
Cerebrovascular accident
Haemorrhage from vascular access or dialysis circuit
Haemorrhage from ruptured vascular aneurysm
Haemorrhage from surgery
Other haemorrhage
Pulmonary infection (bacterial)
Pulmonary infection (viral)
Pulmonary infection (fungal)
Infection elsewhere
Septicaemia
Tuberculosis (lung)
Generalised viral infection
Peritonitis
Viral hepatitis
Cirrhosis, not viral
Gastrointestinal haemorrhage
Mesenteric infarction
Pancreatitis
Sclerosing (or adhesive) peritoneal disease
Perforation of peptic ulcer
Perforation of colon
Patient refused further treatment
Suicide
Therapy ceased for any other reason
Uraemia caused by graft failure
Bone-marrow depression
Cachexia
Malignant disease possibly induced by immunosuppressive therapy
Malignant disease not induced by immunosuppressive therapy
Dementia
Other identified causes
Accident related to treatment
Accident unrelated to treatment
17.5
16.9
16.6
9.5
17.2
0.6
3.1
2.2
14.7
1.8
100
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